Harmful microinjecting practices among a cohort of injection drug users in vancouver canada

Substance Use and Misuse

Volumn 45, Issue 9, 2010, Pages 1351-1366

  Rachlis, Beth ^a   Lloyd Smith, Elisa ^a   Small, Will ^a   Tobin, Diane ^b   Stone, Dave ^b   Li, Kathy ^a   Wood, Evan ^a   Kerr, Thomas ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b VANCOUVER AREA NETWORK OF DRUG USERS   (Canada)

Author keywords

Harmful; Injection drug use; Microinjecting practices; Vancouver

Indexed keywords

ADULT; ARTICLE; CANADA; CAUCASIAN; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG ABUSE; ETHNIC AND RACIAL GROUPS; ETHNOLOGY; FEMALE; HUMAN; INTOXICATION; LONGITUDINAL STUDY; MALE; MICROINJECTION; RISK FACTOR; SOCIAL ENVIRONMENT; SOCIOECONOMICS; STATISTICS; SUBSTANCE ABUSE;

ADULT; BRITISH COLUMBIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MICROINJECTIONS; NEEDLE SHARING; OVERDOSE; POPULATION GROUPS; RISK FACTORS; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77952966765     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826081003767643     Document Type: Article

References (59)

1. Abreu, M. E., Bigelow, G. E., Fleisher, L.,Walsh, S. L. (2001). Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology, 154:76-84.
2. Aceijas, C., Stimson, G. V., Hickman, M., Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS, 18:2295-2303. (Pubitemid 39620222)
3. Broadhead, R. S., Heckathorn, D. D., Weakliem, D. L., Anthony, D. L., Madray, H., Mills, R. J., et al. (1998). Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Reports, 113:42-57.
4. Buxton, J. (2003). Vancouver drug Use Epidemiology. Site Report for the Canadian Community Epidemiology of drug Use. Accessed November 10, 2005, from www.vancouver.ca/ Foupillaro/pdf/report vancouver 2003.pdf
5. Buxton, J. (2007). Vancouver drug use epidemiology. Vancouver, Canada: Canadian Community Epidemiology Network on Drug Use.
6. Buxton, J. A., Preston, E. C., Mak, S., Harvard, S., Barely, J., and BC Harm Reduction supply distribution in British Columbia. (2008).More than just needles: an evidence-informed approach to enhancing harm reduction supply distribution in British Columbia. Harm Reduction Journal, 5:37.
7. Celentano, D. D., Vlahov, D., Cohn, S., Anthony, J. C., Solomon, L., Nelson, K. E. (1991). Risk factors for shooting gallery use among intravenous drug users. American Journal of Public Health, 811, 1291-1295.
8. Centers for Disease Control and Prevention (CDC). (2009). HIV infection among injection drug users-34 states, 2004-2007. MMWR Morbidity and Mortality Weekly, 58:1291-1295.
9. Ceste, J. (2007). Aids and Public Security: The other side of the coin. Lancet, 369:720-721.
10. Corneil, T. A., Kuyper, L. M., Shoveller, J., Hogg, R. S., Li, K., Spittal, P. M., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health and Place, 12:79-85.
11. Csete, J., Cohen, J. (2003). Human rights in Vancouver: Do injection drug users have a fuend in city hall. Canadian HIV/AID Policy and Law Review, 8:7-10.
12. Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51:253-263.
13. Des Jarlais, D. C., Arasteh, K., Semaan, S., Wood, E. (2009). HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. Current Opinions on HIV/AIDS, 4:308-313.
14. Des Jarlais, D., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., et al. (2000). HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. American Journal of Public Health, 90:352-359. (Pubitemid 30115408)
15. Dovey, K., Fitzgerald, J. L., Choi, Y. (2001). Safety becomes danger: dilemmas of drug-use in public space. Health and Place, 7, 319-331.
16. Dwyer, R., Topp, L., Maher, L., Power, R., Hellard, M., Walsh, N., et al. (2009). Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug and Alcohol Dependence, 100:9-16.
17. Eby, D. (2006). The political power of police and crackdowns: Vancouver's example. International Journal of Drug Policy, 17:96-100.
18. Fast, D., Small,W.,Wood, E., Kerr, T. (2008). The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduction Journal, 5:32.
19. Freeman, R., Williams, M. L., Sanders, L. A. (1999). Drug use, AIDS knowledge and HIV risk behaviours of Cuban-, Mexican-, and Puerto Rican-born drug injectors who are recent entrants into the United States. Substance Use and Misuse, 34:1765-1793.
20. Friedman, S. R., Reid, G. (2002). The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology, 22:177-200.
21. Galea, S., Nandi,A., Vlahov,D. (2004). The social epidemiology of drug use. Epidemiologic Reviews, 26:36-52.
22. Hagan, H., Des Jarlais, D. C. (2000). HIV and HCV infection among injecting drug users. Mt. Sinai Journal of Medicine, 67:423-428.
23. Hamers, F. F., Batter, V., Downo, A. M., Alix, J., Cazein, F., Brunet, J. B. (1997). The HIV epidemic associated with injection drug use in Europe: geographic and time trends. AIDS, 11:1365-1374.
24. Haw, S., Higgins, K. (1998). A comparison of the prevalence of HIV infection and injecting risk behaviour in urban and rural samples in Scotland. Addiction, 93:855-863.
25. Hurley, S. F., Jolley, D. J. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797-1801.
26. Kerr, T., Small, W., Peeace, W., Douglas, D., Pierre, A., Wood, E. (2006). Harm reduction by a 'user-run' organization: a case study of the Vancouver Area Network of Drug Users (VANDU). International Journal of Drug Policy, 17:61-69.
27. Kleinig, J., Einstein, S., (2006). Ethical challenges for intervening in drug use: policy, research and treatment issues. Huntsville, TX: OICJ.
28. Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., Kerr, T. (2008). Risk factors for developing cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health, 9:405.
29. Lloyd-Smith, E., Kerr, T., Hogg, R. S., Li, K., Montaner, J. S., Wood, E. (2005). Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduction Journal, 2:24.
30. Maas, B., Fairbairn, N., Kerr, T., Li, K., Montaner, J. S. G., Wood, E. (2007). Neighbourhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health and Place, 17:432-439.
31. Magura, S., Kang, S. Y., Nwakeze, P. C., Demsky, S. (1998). Temporal patterns of heroin and cocaine use among methadone patients. Substance Use and Misuse, 33:2441-2467.
32. Maher, L., Dixon, D. (1995). Policing and public health: law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39:488-512.
33. Miller, C., Strathdee, S. A.,Kerr, T., Li, K.,Wood, E. (2006a). Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. Journal of Adolescent Health, 38:462-464.
34. Miller, C. L., Kerr, T., Frankish, J. C., Spittal, P. M., Li, K., Schechter, M. T., et al. (2006b). Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Substance Use and Misuse, 41:199-210.
35. Milloy, M. J., Wood, E., Small, W., Tyndall, M., Lai, C., Montaner, J., et al. (2008). Incarceration experiences in a cohort of active injection drug users. Drug and Alcohol Review, 27:693-699.
36. Ouellet, L., Jimenez, A. D., Johnson, W., Wiebel, W. (1991). Shooting galleries and HIV disease variations in places for injecting illicit drugs. Crime and Deliquency, 37:64-85.
37. Palepu, A., Tyndall, M. W., Leon, H., Muller, J., O'Shaughnessy, M. V., Schechter, M. T., et al. (2001). Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal,165;415-420.
38. Patrick, D. M., Tyndall, M.W., Cornelisse, P. G., Li, K., Sherlock, C. H., Rekart, M. L., et al. (2001). Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ, 165:889-895.
39. Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., et al. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STDs and AIDS, 8:437-445.
40. Rhodes, T. (2002). The 'risk' environment: a framework for understanding and reducing drug related harm. International Journal of Drug Policy, 13:85-94.
41. Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61:1026-1044.
42. Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., et al. (2006). Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction, 101:1385-1393.
43. Shannon, K., Kerr, T., Allinott, S., Chettiar, J., Shoveller, J., Tyndall, M. W. (2007). Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Social Science and Medicine, 66:911-921.
44. Small, W., Rhodes, T., Wood, E., Kerr, T. (2007). Public injection settings in Vancouver: physical environment, social context and risk. International Journal of Drug Policy, 18:27-36.
45. Small,W.,Kerr, T., Charette, J., Schechter, M. T., Spitall, P. M. (2006). Impacts of an intensified police activity on injection drug users: evidence from an ethnographic investigation. International Journal of Drug Policy, 17:85-95.
46. Song, J. Y., Safaeian, M., Strathdee, S. A., Vlahov, D., Celentano, D. D. (2000). The prevalence of homelessness among injection drug users with and without HIV infection. Journal of Urban Health, 77, 678-687. (Pubitemid 32059235)
47. Spittal, P. M., Craib, K. J., Teegee, M., Baylis, C., Christian, W. M., Moniruzzaman, A. K., et al. (2007). The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. International Journal of Circumpolar Health, 66:226-240
48. Spradling, P. R., Richardson, J. T., Buchacz, K., Moorman, A. C., Finelli, L., Bell, B. P., Brooks, J. T., the HIV Outpatient Study Investigators. (2010). Trends in hepatitis C virus infection among patients in the HIV outpatient study, 1996-2007. Journal of the Acquired Immune Deficiency Syndromes. 53:388-396.
49. Strathdee, S. A., van Ameijden, E. J., Mesquita, F.,Wodak, A., Rana, S., Vlahov, D. (1998). Can HIV epidemics among injection drug users be prevented? AIDS, 12, s71-s79.
50. Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M., Montaner, J. S. G., et al. (1997a). Needle exchange is not enough: lessons from the Vancouver injecting drug users study. AIDS, 11;F59-F65.
51. Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G., Rekart, M., et al. (1997b). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92:1339-1347
52. Tyndall, M. W., Currie, P., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17;887-893.
53. Tyndall, M. W., Craib, K. J. P., Currie, S., Li, K., O'Shaughnessy, M. V., Schechter, M. T. (2001). Impact of HIV infection on mortality in a cohort of injection drug users. Journal of the Acquired Immune Deficiency Syndrome, 28:351-357.
54. Wood, A. R., Wood, E., Lai, C., Tyndall, M. W., Montaner, J. S. G., Kerr, T. (2008). Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. International Journal of Drug Policy. 19:183-188.
55. Wood, E., Montaner, J. S., Li, K., Zhang, R., Barney, L., Strathdee, S. A., et al. (2008). Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. American Journal of Public Health, 98:515-519.
56. Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Kerr, T., Hogg, R. S., et al. (2001). Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? Canadian Medical Association Journal, 165, 405-410.
57. Wood, E., Kerr, T. (2006). What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. International Journal of Drug Policy, 17:55-60.
58. Wood, E., Kerr, T., Spittal, P. M., Small,W., Tyndall, M.W., O'Shaughnessy,M. V., et al. (2003). An evaluation of a peer-run 'unsanctioned' syringe exchange program. Journal of Urban Health, 80:455-464.
59. Wood, E., Spittal, P. M., Li, K., Ken, T., Miller, C. L., Nogg, R. S., Montaner, J. S., Schechter, M. T. (2004). Inability to access addiction treatment and risk of HIV-infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 36:750-754.